Literature DB >> 8623134

Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians.

B R Curtis1, R H Aster.   

Abstract

BACKGROUND: About 5 to 10 percent of Asians have platelets that lack the major membrane glycoprotein (GP) IV (CD36, GPIIIb) that carries the isoantigen Naka. The GPIV-negative platelet phenotype is extremely rare among whites, but its frequency in persons of African ancestry has not yet been determined. Isoimmunization against GPIV can occur in GPIV-negative persons and can lead to platelet transfusion refractoriness. Therefore, the expression of GPIV on platelets from unrelated African Americans was studied. STUDY DESIGN AND METHODS: Platelets were obtained from 250 African American and 280 white blood donors. Flow cytometry was used to determine the ability of these platelets to bind a monoclonal antibody that reacted with GPIV. Platelets that failed to react with this probe were tested with other GPIV-specific monoclonal antibodies and with anti-Naka, an isoantibody that recognizes an epitope on GPIV.
RESULTS: Platelets from 6 of the 250 African American donors (2.4%) lacked GPIV and failed to bind anti-Naka, whereas platelets from all of the white donors were GPIV positive (p>0.05). No platelet-reactive antibodies were identified in the serum of the GPIV-negative donors.
CONCLUSION: The frequency of the GPIV-negative platelet phenotype in African Americans is comparable to that in Asians and much greater than that in whites. Studies are needed to determine the frequency with which African Americans become isoimmunized to GPIV by transfusions and the possible contribution of this isoimmunization to platelet transfusion refractoriness in this population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623134     DOI: 10.1046/j.1537-2995.1996.36496226147.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.

Authors:  Tahar Hajri; Xiao Xia Han; Arend Bonen; Nada A Abumrad
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation.

Authors:  S Ohidar Rahaman; Wojciech Swat; Maria Febbraio; Roy L Silverstein
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.

Authors:  Alex F Sandes; Mihoko Yamamoto; Sergio Matarraz; Maria de Lourdes L F Chauffaille; Sandra Quijano; Antonio López; Tsutomu Oguro; Eliza Y S Kimura; Alberto Orfao
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

4.  Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

Authors:  Latisha Love-Gregory; Richard Sherva; Lingwei Sun; Jon Wasson; Timothy Schappe; Alessandro Doria; D C Rao; Steven C Hunt; Samuel Klein; Rosalind J Neuman; M Alan Permutt; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2008-02-27       Impact factor: 6.150

5.  Differential intolerance to loss of function and missense mutations in genes that encode human matricellular proteins.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  J Cell Commun Signal       Date:  2021-01-07       Impact factor: 5.782

6.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.

Authors:  Victor A Drover; Mohammad Ajmal; Fatiha Nassir; Nicholas O Davidson; Andromeda M Nauli; Daisy Sahoo; Patrick Tso; Nada A Abumrad
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

Review 7.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

8.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

9.  Variants of CD36 gene and their association with CD36 protein expression in platelets.

Authors:  Xianguo Xu; Ying Liu; Xiaozhen Hong; Shu Chen; Kairong Ma; Xiaofei Lan; Yanling Ying; Ji He; Faming Zhu; Hangjun Lv
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

10.  Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes.

Authors:  Andrew E Fry; Anita Ghansa; Kerrin S Small; Alejandro Palma; Sarah Auburn; Mahamadou Diakite; Angela Green; Susana Campino; Yik Y Teo; Taane G Clark; Anna E Jeffreys; Jonathan Wilson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Michael J Griffiths; Norbert Peshu; Thomas N Williams; Charles R Newton; Kevin Marsh; Malcolm E Molyneux; Terrie E Taylor; Kwadwo A Koram; Abraham R Oduro; William O Rogers; Kirk A Rockett; Pardis C Sabeti; Dominic P Kwiatkowski
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.